W F Stafford|D A Yphantis - JoVE Visualize

Showing results (61-70 of 75) with videos related to

Pageof 8

Sort By:

Journal of Molecular Biology|March 13, 2001

Calcium-dependent structural changes in scallop heavy meromyosinW F Stafford, M P Jacobsen, J Woodhead, et al.

The Journal of Biological Chemistry|November 10, 1984

Proteolytic susceptibility of both isolated and bound light chains from various myosins to myopathic hamster proteaseS S Margossian, P D Chantler, J R Sellers, et al.

European Biophysics Journal : EBJ|May 9, 2023

Sedimentation velocity FDS studies of antibodies in pooled human serumJ J Correia, G R Bishop, P B Kyle, et al.

Journal of Muscle Research and Cell Motility|February 1, 1993

Functional effects of LC1-reassociation with cardiac papain Mg.S1S S Margossian, H D White, J Lefford, et al.

The Journal of Biological Chemistry|October 5, 1991

Glycosylated and unglycosylated recombinant-derived human stem cell factors are dimeric and have extensive regular secondary structureT Arakawa, D A Yphantis, J W Lary, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 15, 1993

Multiple oligomeric states regulate the DNA binding of helix-loop-helix peptidesR Fairman, R K Beran-Steed, S J Anthony-Cahill, et al.

Science (New York, N.Y.)|February 21, 1992

Molecular characterization of helix-loop-helix peptidesS J Anthony-Cahill, P A Benfield, R Fairman, et al.

Cell Biophysics|January 1, 1994

Tumor targeting in a murine tumor xenograft model with the (sFv')2 divalent form of anti-c-erbB-2 single-chain FvJ S Huston, G P Adams, J E McCartney, et al.

Cancer Research|September 1, 1993

Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain FvG P Adams, J E McCartney, M S Tai, et al.

Protein Engineering|March 1, 1995

Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptidesJ E McCartney, M S Tai, R M Hudziak, et al.

Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:

Pageof 8

Journal of Molecular Biology|March 13, 2001

Calcium-dependent structural changes in scallop heavy meromyosinW F Stafford, M P Jacobsen, J Woodhead, et al.

The Journal of Biological Chemistry|November 10, 1984

Proteolytic susceptibility of both isolated and bound light chains from various myosins to myopathic hamster proteaseS S Margossian, P D Chantler, J R Sellers, et al.

European Biophysics Journal : EBJ|May 9, 2023

Sedimentation velocity FDS studies of antibodies in pooled human serumJ J Correia, G R Bishop, P B Kyle, et al.

Journal of Muscle Research and Cell Motility|February 1, 1993

Functional effects of LC1-reassociation with cardiac papain Mg.S1S S Margossian, H D White, J Lefford, et al.

The Journal of Biological Chemistry|October 5, 1991

Glycosylated and unglycosylated recombinant-derived human stem cell factors are dimeric and have extensive regular secondary structureT Arakawa, D A Yphantis, J W Lary, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 15, 1993

Multiple oligomeric states regulate the DNA binding of helix-loop-helix peptidesR Fairman, R K Beran-Steed, S J Anthony-Cahill, et al.

Science (New York, N.Y.)|February 21, 1992

Molecular characterization of helix-loop-helix peptidesS J Anthony-Cahill, P A Benfield, R Fairman, et al.

Cell Biophysics|January 1, 1994

Tumor targeting in a murine tumor xenograft model with the (sFv')2 divalent form of anti-c-erbB-2 single-chain FvJ S Huston, G P Adams, J E McCartney, et al.

Cancer Research|September 1, 1993

Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain FvG P Adams, J E McCartney, M S Tai, et al.

Protein Engineering|March 1, 1995

Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptidesJ E McCartney, M S Tai, R M Hudziak, et al.

Pageof 8